card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Navigating Clinical Complexity with Confidence

New Publication from Christopher Groves
Navigating Clinical Complexity with Confidence
Home / Insights / Navigating Clinical Complexity with Confidence

Published in Cytometry Part B: Clinical Cytometry

 

In clinical flow cytometry, real-world scenarios often demand flexibility. The latest manuscript by Christopher Groves and co-authors, "Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories", provides essential guidance for laboratories facing unique patient needs.

 

This work addresses a critical gap in current standards, offering practical recommendations beyond CLSI H62 for temporary, case-specific assay modifications. It emphasizes:

  • Preserving assay integrity while adapting to clinical demands
  • Evaluating impact on fluorescence compensation, antibody binding, and sensitivity
  • Safeguarding performance without permanent protocol changes

 

These best practices empower labs to maintain diagnostic excellence while responding to complex clinical situations—ultimately optimizing patient care.

 


Download Document